← back to search

Doreen William

Max Planck Institute of Molecular Cell Biology and Genetics · DE
Area of research
Genetics · Cancer Research
Research interest
Research interests include Glioma Diagnosis and Treatment, Cancer Genomics and Diagnostics, Genetic factors in colorectal cancer, and Cancer Research and Treatments.
h-index
17
citations
800
works
56
NIH funding
primary concept
Medicine
email

Recent publications

Long-read genome and RNA sequencing resolve a pathogenic intronic germline LINE-1 insertion in APC
npj Genomic Medicine 2025cited by 5position: middledoi
Identification of novel snoRNA-based biomarkers for clear cell renal cell carcinoma from urine-derived extracellular vesicles
Biology Direct 2024cited by 15position: middledoi
Benchmarking whole exome sequencing in the German network for personalized medicine
European Journal of Cancer 2024cited by 9position: middledoi
Exploring evolutionary trajectories in ovarian cancer patients by longitudinal analysis of ctDNA
Clinical Chemistry and Laboratory Medicine (CCLM) 2024cited by 6position: middledoi
Plasma extracellular vesicle messenger RNA profiling identifies prognostic EV signature for non-invasive risk stratification for survival prediction of patients with pancreatic ductal adenocarcinoma
Journal of Hematology & Oncology 2023cited by 29position: middledoi
Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers
Annals of Oncology 2022cited by 75position: middledoi
Different Effects of RNAi-Mediated Downregulation or Chemical Inhibition of NAMPT in an Isogenic IDH Mutant and Wild-Type Glioma Cell Model
International Journal of Molecular Sciences 2022cited by 9position: middledoi
Combined Systemic Drug Treatment with Proton Therapy: Investigations on Patient-Derived Organoids
Cancers 2022cited by 8position: middledoi
Sensitization of Patient-Derived Colorectal Cancer Organoids to Photon and Proton Radiation by Targeting DNA Damage Response Mechanisms
Cancers 2022cited by 6position: middledoi
Treatment of Pheochromocytoma Cells with Recurrent Cycles of Hypoxia: A New Pseudohypoxic In Vitro Model
Cells 2022cited by 4position: middledoi
Patient-Derived Organoids of Cholangiocarcinoma
International Journal of Molecular Sciences 2021cited by 57position: middledoi
Targeted Quantification of Carbon Metabolites Identifies Metabolic Progression Markers and an Undiagnosed Case of SDH-Deficient Clear Cell Renal Cell Carcinoma in a German Cohort
Metabolites 2021cited by 2position: firstdoi
Synergistic Highly Potent Targeted Drug Combinations in Different Pheochromocytoma Models Including Human Tumor Cultures
Endocrinology 2019cited by 41position: middledoi
Optimizing Genetic Workup in Pheochromocytoma and Paraganglioma by Integrating Diagnostic and Research Approaches
Cancers 2019cited by 38position: middledoi
The tuberculosis necrotizing toxin is an NAD+ and NADP+ glycohydrolase with distinct enzymatic properties
Journal of Biological Chemistry 2018cited by 39position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Barbara Klink · University of Luxembourg6 papers (2019–2022)Evelin Schröck · German Cancer Research Center6 papers (2019–2025)Daniela E. Aust · Helmholtz-Zentrum Dresden-Rossendorf5 papers (2019–2025)Susan Richter · University of Auckland4 papers (2019–2022)Konrad Grützmann · Zimmer Biomet (Netherlands)4 papers (2021–2024)Alexander Krüger · Helmholtz-Zentrum Dresden-Rossendorf3 papers (2023–2024)Jürgen Weitz · University Medical Center Hamburg-Eppendorf3 papers (2021–2023)Graeme Eisenhofer · Tufts University3 papers (2019–2022)Stephan Drukewitz · Leipzig University3 papers (2022–2024)Rebecca Bütof · Helmholtz-Zentrum Dresden-Rossendorf2 papers (2022–2022)Gustavo Baretton · National Center for Tumor Diseases2 papers (2024–2024)Anna Jana Lößner · German Cancer Research Center2 papers (2022–2022)Max Naumann · German Cancer Research Center2 papers (2022–2022)Svenja Nölting · Eunice Kennedy Shriver National Institute of Child Health and Human Development2 papers (2019–2022)Cläre von Neubeck · Essen University Hospital2 papers (2022–2022)Kati Erdmann · Klinik und Poliklinik für Urologie2 papers (2021–2024)S. Füssel · University Hospital Carl Gustav Carus2 papers (2021–2024)Daniel E. Stange · German Cancer Research Center2 papers (2022–2022)Tabea Czempiel · German Cancer Research Center2 papers (2022–2022)Kristin Pape · German Cancer Research Center2 papers (2022–2022)